ArticleAntimicrobial agents and chemotherapy2005

Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.

Monica Fonseca-Aten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.